Cellular uptake of nanoparticles: journey inside the cell
Nanoscale materials are increasingly found in consumer goods, electronics, and
pharmaceuticals. While these particles interact with the body in myriad ways, their beneficial …
pharmaceuticals. While these particles interact with the body in myriad ways, their beneficial …
Antigen presentation and T cell stimulation by dendritic cells
P Guermonprez, J Valladeau, L Zitvogel… - Annual review of …, 2002 - annualreviews.org
Dendritic cells take up antigens in peripheral tissues, process them into proteolytic peptides,
and load these peptides onto major histocompatibility complex (MHC) class I and II …
and load these peptides onto major histocompatibility complex (MHC) class I and II …
Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis
JS Wadia, RV Stan, SF Dowdy - Nature medicine, 2004 - nature.com
The TAT protein transduction domain (PTD) has been used to deliver a wide variety of
biologically active cargo for the treatment of multiple preclinical disease models, including …
biologically active cargo for the treatment of multiple preclinical disease models, including …
Imaging macrophages with nanoparticles
Nanomaterials have much to offer, not only in deciphering innate immune cell biology and
tracking cells, but also in advancing personalized clinical care by providing diagnostic and …
tracking cells, but also in advancing personalized clinical care by providing diagnostic and …
Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo
JMM Den Haan, SM Lehar, MJ Bevan - The Journal of experimental …, 2000 - rupress.org
Bone marrow–derived antigen-presenting cells (APCs) take up cell-associated antigens and
present them in the context of major histocompatibility complex (MHC) class I molecules to …
present them in the context of major histocompatibility complex (MHC) class I molecules to …
Cell biology of antigen processing in vitro and in vivo
ES Trombetta, I Mellman - Annu. Rev. Immunol., 2005 - annualreviews.org
▪ Abstract The conversion of exogenous and endogenous proteins into immunogenic
peptides recognized by T lymphocytes involves a series of proteolytic and other enzymatic …
peptides recognized by T lymphocytes involves a series of proteolytic and other enzymatic …
Presentation of exogenous protein antigens on major histocompatability complex class I molecules by dendritic cells: pathway of presentation and regulation by …
P Brossart, MJ Bevan - Blood, The Journal of the American …, 1997 - ashpublications.org
Several recent studies have shown that dendritic cells (DC) pulsed with soluble proteins can
present peptide epitopes derived from these exogenous antigens on major …
present peptide epitopes derived from these exogenous antigens on major …
Macropinocytosis: an endocytic pathway for internalising large gulps
JP Lim, PA Gleeson - Immunology and cell biology, 2011 - Wiley Online Library
Macropinocytosis is a regulated form of endocytosis that mediates the non‐selective uptake
of solute molecules, nutrients and antigens. It is an actin‐dependent process initiated from …
of solute molecules, nutrients and antigens. It is an actin‐dependent process initiated from …
Origin, maturation and antigen presenting function of dendritic cells
Dendritic cells are cells specialized for antigen capture, migration and T cell stimulation.
Recent advances have been made in understanding their origin, their heterogeneity, the …
Recent advances have been made in understanding their origin, their heterogeneity, the …
mRNA vaccines: The dawn of a new era of cancer immunotherapy
Z Deng, Y Tian, J Song, G An, P Yang - Frontiers in Immunology, 2022 - frontiersin.org
mRNA therapy is a novel anticancer strategy based on in vitro transcription (IVT), which has
potential for the treatment of malignant tumors. The outbreak of the COVID-19 pandemic in …
potential for the treatment of malignant tumors. The outbreak of the COVID-19 pandemic in …